BioSpace News Archive

Neurovascular Company Perfuze Raises €22.5m ($25m) Series A for New Stroke Treatment

Perfuze, a medical device company developing next-generation catheter-based aspiration technology to treat large vessel occlusion acute ischemic stroke, has closed a €22.5 million Series A investment round.

February 9, 2022

·

5 min read

Business

Mainz Biomed Appoints Oncology Expert Dr. Rainer Metzger to Strategic Advisory Board

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced the appointment of Dr. Rainer Metzger to its Strategic Advisory Board.

February 9, 2022

·

6 min read

Active Biotech enters into global patent license agreement with Oncode Institute for tasquinimod in myelofibrosis

Active Biotech announced it has entered into an exclusive license agreement with Oncode Institute in the Netherlands, for the global rights to patents relating to the use of tasquinimod and other inhibitors of S100 for use in treatment of myelofibrosis.

February 9, 2022

·

4 min read

Core One Labs’ Successful Patent Application Filing for Protection of its Biosynthetic Production System for Psilocybin Marks a Significant Milestone for the Progression of Psychedelic Health Care

Core One Labs Inc. is pleased to announce that following its milestone announcement that its wholly-owned subsidiary, Vocan Biotechnologies Inc. ( Vocan ), has successfully engineered a novel recombinant production system for biologically synthesized (biosynthesized) psilocybin.

February 9, 2022

·

5 min read

Genetown

EdiGene and Neukio Enter Collaboration to Develop Next-Generation Immune Cell Therapies

EdiGene, Inc. and Neukio Biotherapeutics announced an R&D collaboration to develop next-generation immune cell therapies.

February 9, 2022

·

3 min read

Business

Theravance Biopharma to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022

Theravance Biopharma, Inc. will report its fourth quarter and full year 2021 financial results and provide a business update after market close on Wednesday, February 23, 2022.

February 9, 2022

·

2 min read

Biotech Beach

ChromaDex Announces Issuance of New U.S. Continuation Patent, Expanding Intellectual Property Portfolio for Nicotinamide Riboside

ChromaDex Corp. (NASDAQ:CDXC) today announced that it was granted a continuation patent, adding to its global patent portfolio surrounding nicotinamide riboside.

February 9, 2022

·

3 min read

Business

Foundation Medicine Announces Global Collaboration With Lilly to Develop FoundationOne®CDx and FoundationOne®Liquid CDx as Companion Diagnostics for RETEVMO® and Loxo Oncology at Lilly’s Pipeline Programs

Foundation Medicine, Inc. today announced a collaboration with Eli Lilly and Company (Lilly) for the development of Foundation Medicine’s tissue- and blood-based assays as companion diagnostics for RETEVMO.

February 9, 2022

·

5 min read

Pharm Country

BioXcel Therapeutics to Present at the SVB Leerink 11th Annual Global Healthcare Conference

BioXcel Therapeutics, Inc. today announced that Vimal Mehta, Ph.D., Founder and Chief Executive Officer, will present at the upcoming SVB Leerink 11th Annual Global Healthcare Conference on Wednesday, February 16 at 2:20 p.m. ET.

February 9, 2022

·

3 min read

Biotech Beach

Connect Biopharma to Participate at the SVB Leerink 11th Annual Global Healthcare Conference

Connect Biopharma Holdings Limited announced that Dr. Zheng Wei, Co-Founder & CEO, will participate in a fireside chat at the SVB Leerink 11th Annual Global Healthcare Conference on Wednesday, February 16, 2022 at 4:20 pm ET.

February 9, 2022

·

1 min read